Quarterly report [Sections 13 or 15(d)]

Inventory

v3.25.1
Inventory
3 Months Ended
Feb. 28, 2025
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

Inventory is comprised of public cord blood banking specimens, collection kits, finished goods, work-in-process and raw materials. Collection kits are used in the collection and processing of umbilical cord blood and cord tissue stem cells, finished goods include products purchased or assumed for resale and for the use in the Company’s processing and storage service. Inventory in the

Public Cord Blood Bank includes finished goods that are specimens that are available for resale. The Company considers Public Cord Blood Inventory in the Public Cord Blood Bank that has not completed all testing to determine viability to be work in process.

The components of inventory at February 28, 2025 and November 30, 2024 are as follows:

 

 

 

As of
February 28, 2025

 

 

As of
November 30, 2024

 

Raw materials

 

$

 

 

$

 

Work-in-process

 

 

351,137

 

 

 

207,291

 

Work-in-process – Public Bank

 

 

 

 

 

 

Finished goods

 

 

57,269

 

 

 

71,566

 

Finished goods – Public Bank

 

 

5,200,954

 

 

 

5,279,866

 

Collection kits

 

 

32,753

 

 

 

48,813

 

Inventory reserve

 

 

(7,718

)

 

 

(7,718

)

Total inventory

 

$

5,634,395

 

 

$

5,599,818